Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada for PrEP: A Case Control Study
Phase of Trial: Phase IV
Latest Information Update: 23 Jun 2017
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 10 Jun 2017 Biomarkers information updated
- 25 Jan 2016 Planned End Date changed from 1 Sep 2016 to 1 Apr 2018 as reported by ClinicalTrials.gov record.
- 25 Jan 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Apr 2018 as reported by ClinicalTrials.gov record.